Ultragenyx Pharmaceutical, Inc. (NASDAQ:RARE) Q1 2024 Earnings Conference Call May 2, 2024 5:00 PM ET Company Participants Joshua Higa - Vice President of Investor Relations Emil Kakkis - Chief Executive Officer & President Erik Harris - Chief Commercial Officer Howard Horn - Chief Financial Officer Eric Crombez - Chief Medical Officer Conference Call Participants Yigal Nochomovitz - Citigroup Anupam Rama – JPMorgan Tazeen Ahmad - Bank of America Securities Gena Wang – Barclays Dae Gon Ha – Stifel Kristen K ...